Your browser doesn't support javascript.
loading
A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.
Kholia, Sharad; Jorfi, Samireh; Thompson, Paul R; Causey, Corey P; Nicholas, Anthony P; Inal, Jameel M; Lange, Sigrun.
Afiliação
  • Kholia S; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, UK.
  • Jorfi S; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, UK.
  • Thompson PR; Department of Chemistry, The Scripps Research Institute, Jupiter, FL, USA.
  • Causey CP; Department of Chemistry, University of North Florida, Jacksonville, FL, USA.
  • Nicholas AP; Department of Neurology, University of Alabama at Birmingham, Birmingham, VA, USA.
  • Inal JM; Birmingham VA Medical Center, Birmingham, AL, USA.
  • Lange S; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, UK; j.inal@londonmet.ac.uk.
J Extracell Vesicles ; 4: 26192, 2015.
Article em En | MEDLINE | ID: mdl-26095379

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Extracell Vesicles Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Extracell Vesicles Ano de publicação: 2015 Tipo de documento: Article